Garland Eric L
Department of Psychiatry, University of California-San Diego, La Jolla, California, USA.
Sanford Institute for Empathy and Compassion, University of California-San Diego, La Jolla, California, USA.
Br J Clin Pharmacol. 2024 Dec;90(12):3028-3035. doi: 10.1111/bcp.16147. Epub 2024 Jul 24.
The opioid crisis emerged in part due to the overprescribing of opioid analgesics for chronic pain. Although not the only source of the current epidemic of opioid use disorder (OUD), the prescription of opioids for chronic pain remains one vector for the development of opioid misuse and OUD. However, opioid tapering is not appropriate for all patients, and some patients may need to remain on opioid therapy for the long term. To reduce the risk of opioid-related harm among people with chronic pain and to treat incipient or entrenched addictive behaviours, new interventions are needed. This review discusses the clinical outcomes, biobehavioural mechanisms and implementation considerations for a novel, evidence-based intervention for chronic pain, opioid use and OUD called Mindfulness-Oriented Recovery Enhancement (MORE). MORE unites complementary aspects of mindfulness training, cognitive behavioural therapy and principles from positive psychology to simultaneously address addictive behaviour, emotion dysregulation and chronic pain by targeting brain reward and stress systems. MORE has been tested in 13 completed randomized clinical trials, including over 1300 patients, and has demonstrated efficacy against a range of active control conditions for reducing opioid dosing, opioid misuse, illicit drug use, depression, post-traumatic stress symptoms and chronic pain. Opportunities for implementing MORE include facilitating opioid tapering and promoting safe opioid use in primary care and specialty pain clinics, decreasing opioid misuse and enhancing medication-assisted treatment for OUD. Given evidence of MORE's efficacy, it is now time to consider disseminating this evidence-based treatment in the United States, the United Kingdom and worldwide.
阿片类药物危机的出现部分归因于阿片类镇痛药在慢性疼痛治疗中的过度处方。尽管并非当前阿片类药物使用障碍(OUD)流行的唯一源头,但用于慢性疼痛的阿片类药物处方仍是阿片类药物滥用和OUD发展的一个途径。然而,逐渐减少阿片类药物剂量并不适用于所有患者,一些患者可能需要长期接受阿片类药物治疗。为降低慢性疼痛患者中与阿片类药物相关的伤害风险,并治疗初期或根深蒂固的成瘾行为,需要新的干预措施。本综述讨论了一种名为“正念导向康复强化法”(MORE)的针对慢性疼痛、阿片类药物使用和OUD的新型循证干预措施的临床结果、生物行为机制及实施考量。MORE将正念训练、认知行为疗法的互补方面与积极心理学的原则结合起来,通过针对大脑奖赏和应激系统,同时解决成瘾行为、情绪调节障碍和慢性疼痛问题。MORE已在13项完成的随机临床试验中进行了测试,涉及1300多名患者,并已证明在一系列活性对照条件下,对于减少阿片类药物剂量、阿片类药物滥用、非法药物使用、抑郁、创伤后应激症状和慢性疼痛具有疗效。实施MORE的机会包括在初级保健和专科疼痛诊所促进阿片类药物剂量的逐渐减少及促进阿片类药物的安全使用、减少阿片类药物滥用以及加强对OUD的药物辅助治疗。鉴于MORE疗效的证据,现在是时候考虑在美国、英国及全球推广这种循证治疗方法了。